Rectal NETs and Rectosigmoid Junction NETs May Need to Be Treated Differently

#2767

Introduction: Neuroendocrine tumours (NETs) are heterogeneous, and the incidence of colorectal NETs is rapidly increasing.

Aim(s): We observed different survival in patients with rectal NETs and rectosigmoid junction NETs, which are unreasonable to be treated similarly.

Materials and methods: We included patients from SEER database. Patients with a rectal NET diagnosis between 2000 and 2016 who met our criteria were included. The 5-year survival was set as the end-point.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author: Cai W

Authors: Cai W, Ge W, Mao J, Hu h,

Keywords: Rectal neuroendocrine tumor, rectosigmoid junction, SEER database, Survival,